{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:50:43Z","timestamp":1791971443285,"version":"4.3.4"},"reference-count":49,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>MiRNAs play a key role in ischemic stroke (IS). Although miR-101-3p can participate in multiple disease processes, its role and mechanism in IS are not clear. The aim of the present study was to observe the effect of miR-101-3p activation on IS in young mice and the role of HDAC9 in this effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The young mice were first subjected to transient middle cerebral artery occlusion (tMCAO) or sham surgery, and the cerebral infarct area was assessed with 2,3,5-triphenyltetrazolium chloride staining. Meanwhile, the expressions of miR-101-3p and HDAC9 were tested using RT-qPCR or western blot. Besides, neuron morphology and apoptosis were confirmed using Nissl staining and TUNEL staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We first verified that miR-101-3p was downregulated and HDAC9 was upregulated in the brain tissue of tMCAO young mice. Moreover, we proved that overexpression of miR-101-3p could improve cerebral infarction, neuronal morphology, and neuronal apoptosis in tMCAO young mice by lowering the expression of HDAC9.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Activation of miR-101-3p can protect against IS in young mice, and its mechanism is relevant to the inhibition of HDAC9. Therefore, miR-101-3p and HDAC9 might be the latent targets for IS therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/tnsci-2022-0286","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:29:31Z","timestamp":1685068171000},"source":"Crossref","is-referenced-by-count":8,"title":["miR-101-3p improves neuronal morphology and attenuates neuronal apoptosis in ischemic stroke in young mice by downregulating HDAC9"],"prefix":"10.1515","volume":"14","author":[{"given":"Mengru","family":"Zhang","sequence":"first","affiliation":[{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine , Shenzhen , 518000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Wang","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine , Shenzhen , 518000 , China"},{"name":"Encephalopathy and Psychology Department, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , 518000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Li","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine , Shenzhen , 518000 , China"},{"name":"Encephalopathy and Psychology Department, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , 518000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanxin","family":"Kong","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine , Shenzhen , 518000 , China"},{"name":"Encephalopathy and Psychology Department, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , 518000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjun","family":"Lin","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine , Shenzhen , 518000 , China"},{"name":"Encephalopathy and Psychology Department, Shenzhen Traditional Chinese Medicine Hospital , Shenzhen , 518000 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"2026101409103547053_j_tnsci-2022-0286_ref_001","doi-asserted-by":"crossref","unstructured":"Guzik A, Bushnell C. Stroke epidemiology and risk factor management. Contin (Minneap Minn). 2017;23:15\u201339.","DOI":"10.1212\/CON.0000000000000416"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_002","doi-asserted-by":"crossref","unstructured":"Sarikaya H, Steinlin M. Cerebellar stroke in adults and children. Handb Clin Neurol. 2018;155:301\u201312.","DOI":"10.1016\/B978-0-444-64189-2.00020-2"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_003","doi-asserted-by":"crossref","unstructured":"Dunbar M, Kirton A. Perinatal stroke. Semin Pediatr Neurol. 2019;32:100767.","DOI":"10.1016\/j.spen.2019.08.003"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_004","doi-asserted-by":"crossref","unstructured":"Ferriero DM, Fullerton HJ, Bernard TJ, Billinghurst L, Daniels SR, DeBaun MR, et al. Management of stroke in neonates and children: A scientific statement from the American Heart Association\/American stroke association. Stroke. 2019;50:e51\u201396.","DOI":"10.1161\/STR.0000000000000183"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_005","doi-asserted-by":"crossref","unstructured":"Doig D, Davagnanam I, Taranath A, Zlatareva D, Alwis A, Siddiqui A, et al. Monogenetic stroke syndromes in children and young adults. Am J Roentgenol. 2020;215:695\u2013705.","DOI":"10.2214\/AJR.19.22360"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_006","unstructured":"Buckowski A, Rose E. Pediatric stroke: diagnosis and management in the emergency department. Pediatr Emerg Med Pract. 2019;16:1\u201320."},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_007","unstructured":"Oborska Z, Urban P, Wychowaniec K, J\u00f3\u017awiak S. Paediatric stroke - a review of current guidelines for diagnosis and treatment. Neurol Neurochir Pol. 2020;54:116\u201324."},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_008","doi-asserted-by":"crossref","unstructured":"Kalayinia S, Arjmand F, Maleki M, Malakootian M, Singh CP. MicroRNAs: roles in cardiovascular development and disease. Cardiovasc Pathol. 2021;50:107296.","DOI":"10.1016\/j.carpath.2020.107296"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_009","doi-asserted-by":"crossref","unstructured":"Tang Q, Wan S, Qiao X, Wang F, Wang Y. MiR-29 promotes ovarian carcinoma cell proliferation through the PTEN pathway. Eur J Gynaecol Oncol. 2020;41:774\u20138.","DOI":"10.31083\/j.ejgo.2020.05.5044"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_010","doi-asserted-by":"crossref","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451\u201365.","DOI":"10.1002\/jcp.27486"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_011","doi-asserted-by":"crossref","unstructured":"Paul S, Reyes PR, Garza BS, Sharma A. MicroRNAs and child neuropsychiatric disorders: A brief review. Neurochem Res. 2020;45:232\u201340.","DOI":"10.1007\/s11064-019-02917-y"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_012","doi-asserted-by":"crossref","unstructured":"Mellis D, Caporali A. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target. Biochem Soc Trans. 2018;46:11\u201321.","DOI":"10.1042\/BST20170037"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_013","doi-asserted-by":"crossref","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203\u201322.","DOI":"10.1038\/nrd.2016.246"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_014","doi-asserted-by":"crossref","unstructured":"Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ. Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci. 2020;21:1723.","DOI":"10.3390\/ijms21051723"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_015","doi-asserted-by":"crossref","unstructured":"Chen J, Cui C, Yang X, Xu J, Venkat P, Zacharek A, et al. MiR-126 Affects brain-heart interaction after cerebral ischemic stroke. Transl Stroke Res. 2017;8:374\u201385.","DOI":"10.1007\/s12975-017-0520-z"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_016","doi-asserted-by":"crossref","unstructured":"Du K, Zhao C, Wang L, Wang Y, Zhang KZ, Shen XY, et al. MiR-191 inhibit angiogenesis after acute ischemic stroke targeting VEZF1. Aging (Albany NY). 2019;11:2762\u201386.","DOI":"10.18632\/aging.101948"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_017","doi-asserted-by":"crossref","unstructured":"Mu J, Cheng X, Zhong S, Chen X, Zhao C. Neuroprotective effects of miR-532-5p against ischemic stroke. Metab Brain Dis. 2020;35:753\u201363.","DOI":"10.1007\/s11011-020-00544-z"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_018","doi-asserted-by":"crossref","unstructured":"Zheng T, Shi Y, Zhang J, Peng J, Zhang X, Chen K, et al. MiR-130a exerts neuroprotective effects against ischemic stroke through PTEN\/PI3K\/AKT pathway. Biomed Pharmacother. 2019;117:109117.","DOI":"10.1016\/j.biopha.2019.109117"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_019","doi-asserted-by":"crossref","unstructured":"Wang H, Guo Y, Mi N, Zhou L. miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1. Mol Cell Probes. 2020;52:101567.","DOI":"10.1016\/j.mcp.2020.101567"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_020","doi-asserted-by":"crossref","unstructured":"Li Z, Qu Z, Wang Y, Qin M, Zhang H. miR-101-3p sensitizes non-small cell lung cancer cells to irradiation. Open Med (Wars). 2020;15:413\u201323.","DOI":"10.1515\/med-2020-0044"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_021","unstructured":"Sun W, Zhang Q, Wu Z, Xue N. miR-101-3p sensitizes hepatocellular carcinoma cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Clin Exp Pathol. 2019;12:2056\u201365."},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_022","doi-asserted-by":"crossref","unstructured":"Jiang H, Li L, Zhang J, Wan Z, Wang Y, Hou J, et al. MiR-101-3p and Syn-Cal14.1a Synergy in Suppressing EZH2-Induced Progression of Breast Cancer. Onco Targets Ther. 2020;13:9599\u2013609.","DOI":"10.2147\/OTT.S264600"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_023","doi-asserted-by":"crossref","unstructured":"Li L, Shao MY, Zou SC, Xiao ZF, Chen ZC. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44. J Neurooncol. 2019;141:19\u201330.","DOI":"10.1007\/s11060-018-2973-7"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_024","doi-asserted-by":"crossref","unstructured":"Xin Y, Tang L, Chen J, Chen D, Wen W, Han F. Inhibition of miR\u2011101\u20113p protects against sepsis\u2011induced myocardial injury by inhibiting MAPK and NF\u2011\u03baB pathway activation via the upregulation of DUSP1. Int J Mol Med. 2021;47:20.","DOI":"10.3892\/ijmm.2021.4853"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_025","doi-asserted-by":"crossref","unstructured":"Liu LP, Zhang J, Pu B, Li WQ, Wang YS. Upregulation of JHDM1D-AS1 alleviates neuroinflammation and neuronal injury via targeting miR-101-3p-DUSP1 in spinal cord after brachial plexus injury. Int Immunopharmacol. 2020;89:106962.","DOI":"10.1016\/j.intimp.2020.106962"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_026","doi-asserted-by":"crossref","unstructured":"Qin Z, Zhu K, Xue J, Cao P, Xu L, Xu Z, et al. Zinc-induced protective effect for testicular ischemia-reperfusion injury by promoting antioxidation via microRNA-101-3p\/Nrf2 pathway. Aging (Albany NY). 2019;11:9295\u2013309.","DOI":"10.18632\/aging.102348"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_027","doi-asserted-by":"crossref","unstructured":"Cepparulo P, Cuomo O, Vinciguerra A, Torelli M, Annunziato L, Pignataro G. Hemorrhagic stroke induces a time dependent upregulation of miR-150-5p and miR-181b-5p in the bloodstream. Front Neurol. 2021;12:736474.","DOI":"10.3389\/fneur.2021.736474"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_028","doi-asserted-by":"crossref","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke; a J Cereb Circulation. 1989;20:84\u201391.","DOI":"10.1161\/01.STR.20.1.84"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_029","doi-asserted-by":"crossref","unstructured":"Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care Med. 2020;48:1654\u201363.","DOI":"10.1097\/CCM.0000000000004597"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_030","doi-asserted-by":"crossref","unstructured":"Rabinstein AA. Update on treatment of acute ischemic stroke. Contin (Minneap Minn). 2020;26:268\u201386.","DOI":"10.1212\/CON.0000000000000840"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_031","doi-asserted-by":"crossref","unstructured":"Wagenaar N, Martinez-Biarge M, van der Aa NE, van Haastert IC, Groenendaal F, Benders MJNL, et al. Neurodevelopment after perinatal arterial ischemic stroke. Pediatrics. 2018;142:e20174164.","DOI":"10.1542\/peds.2017-4164"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_032","doi-asserted-by":"crossref","unstructured":"Lu Q, Wu R, Zhao M, Garcia-Gomez A, Ballestar E. miRNAs as therapeutic targets in inflammatory disease. Trends Pharmacol Sci. 2019;40:853\u201365.","DOI":"10.1016\/j.tips.2019.09.007"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_033","doi-asserted-by":"crossref","unstructured":"Shan Y, Hu J, Lv H, Cui X, Di W. miR-221 exerts neuroprotective effects in ischemic stroke by inhibiting the proinflammatory response. J Stroke Cerebrovasc Dis. 2021;30:105489.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105489"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_034","doi-asserted-by":"crossref","unstructured":"Bu LL, Xie YY, Lin DY, Chen Y, Jing XN, Liang YR, et al. LncRNA-T199678 mitigates \u03b1-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p. Front Aging Neurosci. 2020;12:599246.","DOI":"10.3389\/fnagi.2020.599246"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_035","doi-asserted-by":"crossref","unstructured":"Meng X, Sun Y, Liu S, Mu Y. miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5. Oncol Lett. 2021;21:282.","DOI":"10.3892\/ol.2021.12543"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_036","doi-asserted-by":"crossref","unstructured":"Zhao X, Li S, Wang Z, Bai N, Feng Y. miR\u2011101\u20113p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF\u2011\u03baB pathway. Mol Med Rep. 2021;23:359.","DOI":"10.3892\/mmr.2021.11998"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_037","doi-asserted-by":"crossref","unstructured":"Tang J, Zhuang S. Histone acetylation and DNA methylation in ischemia\/reperfusion injury. Clin Sci (Lond). 2019;133:597\u2013609.","DOI":"10.1042\/CS20180465"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_038","doi-asserted-by":"crossref","unstructured":"Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia\/Reperfusion. Compr Physiol. 2016;7:113\u201370.","DOI":"10.1002\/cphy.c160006"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_039","doi-asserted-by":"crossref","unstructured":"Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3\u201355.","DOI":"10.1007\/978-981-15-3449-2_1"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_040","doi-asserted-by":"crossref","unstructured":"Zhang Y, Sun Z, Jia J, Du T, Zhang N, Tang Y, et al. Overview of histone modification. Adv Exp Med Biol. 2021;1283:1\u201316.","DOI":"10.1007\/978-981-15-8104-5_1"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_041","doi-asserted-by":"crossref","unstructured":"Wu D, Qiu Y, Jiao Y, Qiu Z, Liu D. Small molecules targeting HATs, HDACs, and BRDs in cancer therapy. Front Oncol. 2020;10:560487.","DOI":"10.3389\/fonc.2020.560487"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_042","doi-asserted-by":"crossref","unstructured":"Hou F, Li D, Yu H, Kong Q. The mechanism and potential targets of class II HDACs in angiogenesis. J Cell Biochem. 2018;119:2999\u20133006.","DOI":"10.1002\/jcb.26476"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_043","doi-asserted-by":"crossref","unstructured":"Malhotra R, Mauer AC, Lino Cardenas CL, Guo X, Yao J, Zhang X, et al. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat Genet. 2019;51:1580\u20137.","DOI":"10.1038\/s41588-019-0514-8"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_044","doi-asserted-by":"crossref","unstructured":"Kim B, Sohn HM, Hyun H, Lim W. Effect of HDAC9 inhibition on epithelial-mesenchymal transition in CD133+ prostate cancer cell lines. J Chemother. 2022;34:45\u201354.","DOI":"10.1080\/1120009X.2021.1963615"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_045","doi-asserted-by":"crossref","unstructured":"Linares A, Assou S, Lapierre M, Thouennon E, Duraffourd C, Fromaget C, et al. Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers. Mol Oncol. 2019;13:1534\u201347.","DOI":"10.1002\/1878-0261.12505"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_046","doi-asserted-by":"crossref","unstructured":"Das S, Natarajan R. HDAC9: An Inflammatory Link in Atherosclerosis. Circ Res. 2020;127:824\u20136.","DOI":"10.1161\/CIRCRESAHA.120.317723"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_047","doi-asserted-by":"crossref","unstructured":"Han Y, Sun W, Wang L, Tao S, Tian L, Hao Y, et al. HDAC9 gene is associated with stroke risk in a Chinese population. Exp Biol Med (Maywood). 2013;238:842\u20137.","DOI":"10.1177\/1535370213494650"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_048","doi-asserted-by":"crossref","unstructured":"Zhou X, Guan T, Li S, Jiao Z, Lu X, Huang X, et al. The association between HDAC9 gene polymorphisms and stroke risk in the Chinese population: A meta-analysis. Sci Rep. 2017;7:41538.","DOI":"10.1038\/srep41538"},{"key":"2026101409103547053_j_tnsci-2022-0286_ref_049","doi-asserted-by":"crossref","unstructured":"Chauhan G, Debette S. Genetic risk factors for ischemic and hemorrhagic stroke. Curr Cardiol Rep. 2016;18:124.","DOI":"10.1007\/s11886-016-0804-z"}],"container-title":["Translational Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2022-0286\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2022-0286\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:11:03Z","timestamp":1791969063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/tnsci-2022-0286\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,5,26]]},"published-print":{"date-parts":[[2023,5,26]]}},"alternative-id":["10.1515\/tnsci-2022-0286"],"URL":"https:\/\/doi.org\/10.1515\/tnsci-2022-0286","relation":{},"ISSN":["2081-6936"],"issn-type":[{"value":"2081-6936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"20220286"}}